|
Sep 11
|
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
|
|
Sep 5
|
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
|
|
May 1
|
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F
|